- Home
- IRMD
IRMD
iRadimed Corporation
as of 12-12-2025 3:58pm EST
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
| Founded: | 1992 | Country: | United States |
| Employees: | N/A | City: | ORLANDO |
| Market Cap: | 910.4M | IPO Year: | 2014 |
| Target Price: | $72.00 | AVG Volume (30 days): | 72.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.65 | EPS Growth: | 13.00 |
| 52 Week Low/High: | $47.48 - $98.44 | Next Earning Date: | 11-03-2025 |
| Revenue: | $80,511,268 | Revenue Growth: | 12.91% |
| Revenue Growth (this year): | 15.17% | Revenue Growth (next year): | 10.15% |
AI-Powered IRMD Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of iRadimed Corporation (IRMD)
Director
Avg Cost/Share
$96.61
Shares
3,000
Total Value
$289,837.50
Owned After
28,742
SEC Form 4
CEO, PRESIDENT, CHAIRMAN
Avg Cost/Share
$96.83
Shares
5,000
Total Value
$477,163.36
Owned After
2,297,816
CEO, PRESIDENT, CHAIRMAN
Avg Cost/Share
$92.66
Shares
5,000
Total Value
$463,794.12
Owned After
2,297,816
CEO, PRESIDENT, CHAIRMAN
Avg Cost/Share
$90.33
Shares
5,000
Total Value
$451,814.36
Owned After
2,297,816
Director
Avg Cost/Share
$88.26
Shares
3,000
Total Value
$264,716.52
Owned After
28,742
CEO, PRESIDENT, CHAIRMAN
Avg Cost/Share
$85.71
Shares
5,000
Total Value
$427,957.28
Owned After
2,297,816
CEO, PRESIDENT, CHAIRMAN
Avg Cost/Share
$85.18
Shares
5,000
Total Value
$426,192.64
Owned After
2,297,816
CHIEF FINANCIAL OFFICER
Avg Cost/Share
$84.51
Shares
10,651
Total Value
$900,161.81
Owned After
2,500
SEC Form 4
CEO, PRESIDENT, CHAIRMAN
Avg Cost/Share
$82.41
Shares
5,000
Total Value
$413,216.00
Owned After
2,297,816
CEO, PRESIDENT, CHAIRMAN
Avg Cost/Share
$78.34
Shares
5,000
Total Value
$388,429.48
Owned After
2,297,816
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| HAWKINS JAMES B | IRMD | Director | Dec 9, 2025 | Sell | $96.61 | 3,000 | $289,837.50 | 28,742 | |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Dec 8, 2025 | Sell | $96.83 | 5,000 | $477,163.36 | 2,297,816 | |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Dec 1, 2025 | Sell | $92.66 | 5,000 | $463,794.12 | 2,297,816 | |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Nov 24, 2025 | Sell | $90.33 | 5,000 | $451,814.36 | 2,297,816 | |
| HAWKINS JAMES B | IRMD | Director | Nov 20, 2025 | Sell | $88.26 | 3,000 | $264,716.52 | 28,742 | |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Nov 18, 2025 | Sell | $85.71 | 5,000 | $427,957.28 | 2,297,816 | |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Nov 10, 2025 | Sell | $85.18 | 5,000 | $426,192.64 | 2,297,816 | |
| GLENN JOHN | IRMD | CHIEF FINANCIAL OFFICER | Nov 10, 2025 | Sell | $84.51 | 10,651 | $900,161.81 | 2,500 | |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Nov 3, 2025 | Sell | $82.41 | 5,000 | $413,216.00 | 2,297,816 | |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Oct 27, 2025 | Sell | $78.34 | 5,000 | $388,429.48 | 2,297,816 |
Compare IRMD vs Leading Stocks
See how IRMD stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "IRMD iRadimed Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.